Posts for the 'News & Alerts' Category
Medtronic Lead Recall: Update letter sent with information about lead performance
Medtronic, Inc. recently issued an open letter to patients who have one of their recalled Sprint Fidelis defibrillator leads. The letter, which is dated May 9, 2008, notifies patients that the risk of lead problems remains small and the recommendations they are making to doctors are unchanged. More detailed information about lead performance was sent to physicians the same day, to update their October 2007 communication, now that six months have passed since the recall.
>>INFORMATION: Medtronic Defibrillator Lead Recall
Trasylol recall issued
Although Bayer AG agreed to stop marketing their heart surgery injection Trasylol in November 2007, they are now removing any remaining stock of the drug from the U.S. market following a study published in the New England Journal of Medicine. The Trasylol recall was issued after data from a Canadian study confirmed that those treated with the injection faced a substantial increased risk of death.
>>INFORMATION: Trasylol Recall Lawsuits
Tips to reduce the risk of misdiagnosis malpractice
Many medical misdiagnosis lawsuits are directly attributed to a competent doctor who simply failed to give their full time and attention to the patient they were treating. Disorganization, trying to treat too many patients too quickly or simply being lazy can cause doctors to miss critical symptoms or signals of treatable problems.
Digitek Class Action Lawsuits filed
Two weeks after a nationwide Digitek recall, several class action lawsuits have already been filed on behalf of users who took the heart drug. Manufacturing problems resulted in some tablets being sold with twice as much of the active medication as they were supposed to have. While Digitek class action suits are seeking reimbursement for the cost of the prescription medication and funding for medical monitoring, those who have suffered severe injuries or death after taking Digitek, should consider pursuing an individual lawsuit.
Baxter faces Heparin lawsuits following blood thinner recall
A nationwide heparin recall was issued earlier this year after blood thinner manufactured by Baxter International was found to be linked to a sharp increase in severe allergic-type reactions and deaths. Last week another FDA alert was issued after it was discovered that the tainted heparin may still be in supplies carried at hospitals and medical facilities throughout the United States. Although many companies face potential liability for the contamination, Baxter addressed the heparin lawsuits they face during their annual shareholder’s meeting last week.
>>INFORMATION: Baxter Heparin Lawsuits
Mother’s day campaign for better care at ManorCare Nursing Homes
On Sunday, when families throughout the United States went to visit their mother’s in ManorCare nursing homes for Mother’s Day, they were greeted with a carnation and information calling them to take action to help improve the quality of nursing home care. ManorCare, which was recently purchased by a private equity fund, has failed to fulfill promises made last year to provide quality care and has seen sharp increases in the number of care deficiencies at many of their homes.
>>INFORMATION: Nursing Home Abuse and Neglect
Cosmetic surgery malpractice leads to kidney failure
A new report from the CDC highlights the risks of cosmetic surgery medical malpractice. Three women who thought they were being given a soft-tissue filler injection at a cosmetic clinic recently ended up suffering kidney failure, resulting in hospitalization and dialysis treatment. The CDC has cautioned consumers to be aware of the risks associated with cosmetic procedures and to make sure that the practitioners who perform such procedures are licensed.
Schwab YieldPlus Class Action Suits
Following the recent collapse of share prices for the Schawb Yield Plus Fund, many investors are exploring their legal options to recover money they lost. The lawyers at Saiontz, Kirk & Miles, P.A. represent investors who are pursuing individual claims against Charles Schwab for failing to properly disclose the nature of the risks associated with certain securities held by the bond fund. While Schwab YieldPlus Class Action lawsuits have been filed, individual investors who lost over $10,000.00 will likely be in a better position to recover their losses through an individual claim.
>>PRIOR POST (4/10/2008): Recover Schwab YieldPlus Losses
Ortho Evra recall urged by consumer group
Today the FDA received a petition filed by Public Citizen Health Research Group asking that the agency issue an Ortho Evra recall. The consumer advocacy group asked the FDA to remove the birth control patch from the market due to the risk of serious and potentially fatal injury associated with its use.
>>INFORMATION: Ortho Evra Side Effects
Despite concerns about side effects of Chanitx, Pfizer’s ad campaign resumes
Chantix is a stop smoking drug which was heavily advertised by Pfizer in direct-to-consumer advertisements until earlier this year. Most of the branded ads were pulled after safety concerns emerged about psychiatric side effects of Chantix which could increase the risk of suicide. However, new ad campaigns are beginning to resurface, now with information about the suicide risks disclosed.
>>INFORMATION: Side Effects of Chantix
